3D imaging of human pancreas suggests islet size and endocrine composition influence their loss in type 1 diabetes

Nat Commun. 2025 Dec 11;16(1):11379. doi: 10.1038/s41467-025-66198-6.

Abstract

A high-definition description of pancreatic islets would prove beneficial for understanding the pathophysiology of type 1 diabetes (T1D), yet significant knowledge gaps exist in terms of their size, endocrine cell composition, and number in both health and disease. Here, 3-dimensional (3D) analyses of pancreata from control persons without diabetes (ND) demonstrate approximately 50% of islets are insulin-positive (INS + ) glucagon-negative (GCG-). Non-diabetic individuals positive for a single Glutamic acid decarboxylase autoantibody (GADA + ) yet at increased risk for disease consistently demonstrate endocrine features, including islet volume and cell composition, closely resembling the age-matched ND controls. In contrast, pancreata from individuals with short-duration T1D demonstrate significantly reduced islet density and a dramatic loss of INS + GCG- islets with preservation of large INS + GCG+ islets. The size and cellular composition of pancreatic islets may, therefore, represent influential factors that impact β-cell loss during T1D disease progression.

MeSH terms

  • Adolescent
  • Adult
  • Autoantibodies / immunology
  • Case-Control Studies
  • Diabetes Mellitus, Type 1* / metabolism
  • Diabetes Mellitus, Type 1* / pathology
  • Female
  • Glucagon / metabolism
  • Glucagon-Secreting Cells / metabolism
  • Glucagon-Secreting Cells / pathology
  • Glutamate Decarboxylase / immunology
  • Humans
  • Imaging, Three-Dimensional* / methods
  • Insulin / metabolism
  • Insulin-Secreting Cells / metabolism
  • Insulin-Secreting Cells / pathology
  • Islets of Langerhans* / diagnostic imaging
  • Islets of Langerhans* / metabolism
  • Islets of Langerhans* / pathology
  • Male
  • Middle Aged
  • Organ Size
  • Pancreas* / diagnostic imaging
  • Pancreas* / pathology
  • Young Adult

Substances

  • Glucagon
  • Insulin
  • Autoantibodies
  • Glutamate Decarboxylase